Circulating tumor DNA (ctDNA) dynamics and clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) undergoing front-line chemotherapy

被引：0
|
作者：
Ghidini, M. [1 ]
Hahne, J. C. [2 ]
Senti, C. [3 ]
Tomasello, G. [1 ]
Ratti, M. [3 ]
Heide, T. [4 ]
Garrone, O. [1 ]
Cortellini, A. [5 ]
Passalacqua, R. [3 ]
Valeri, N. [5 ]
机构：
[1] Fdn IRCCS Osped Maggiore Policlin, Oncol Unit, Milan, Italy
[2] ICR, Ctr Mol Pathol, London, England
[3] ASST Cremona Azienda Sociosanitaria Terr, Oncol Unit, Cremona, Italy
[4] Human Technopole, Computat Biol Res Ctr, Milan, Italy
[5] Imperial Coll London, Dept Surg & Canc, London, England
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1355
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2326P
引用
收藏
页码：S1188 / S1188
页数：1
相关论文
共 50 条
  • [1] Circulating tumor DNA (ctDNA) dynamics and clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) undergoing front-line chemotherapy.
    Ghidini, Michele
    Hahne, Jens Claus
    Senti, Chiara
    Tomasello, Gianluca
    Ratti, Margherita
    Heide, Timon
    Garrone, Ornella
    Cortellini, Alessio
    Passalacqua, Rodolfo
    Valeri, Nicola
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 175 - 175
  • [2] Impact of a metastatic site on circulating tumor DNA (ctDNA) analysis in patients (pts) with metastatic colorectal cancer (mCRC).
    Bando, Hideaki
    Nakamura, Yoshiaki
    Taniguchi, Hiroya
    Shiozawa, Manabu
    Yasui, Hisateru
    Esaki, Taito
    Ohta, Takashi
    Denda, Tadamichi
    Satoh, Taroh
    Yamazaki, Kentaro
    Sunakawa, Yu
    Kato, Takeshi
    Goto, Masahiro
    Yuki, Satoshi
    Nishina, Tomohiro
    Oki, Eiji
    Shinozaki, Eiji
    Matsuhashi, Nobuhisa
    Hata, Masayuki
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] Predictors for detecting circulating tumor DNA (ctDNA) in metastatic colorectal cancer (mCRC).
    Pereira, Allan Andresson Lima
    Loree, Jonathan M.
    Davis, Jennifer S.
    Lam, Michael
    Morris, Van Karlyle
    Overman, Michael J.
    Raghav, Kanwal Pratap Singh
    Kee, Bryan K.
    Fogelman, David R.
    Sanchez, Eduardo Vilar
    Shureiqi, Imad
    Eng, Cathy
    Manuel, Shanequa
    Crosby, Shadarra
    Wolff, Robert A.
    Lanman, Richard B.
    Talasaz, AmirAli
    Janku, Filip
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [4] Circulating tumor DNA (ctDNA) heterogeneity as first- and third-line treatment in patients (pts) with metastatic colorectal cancer (mCRC) treated with panitumumab
    Parseghian, Christine Megerdichian
    Beutner, Karl
    Boedigheimer, Michael
    Ruff, Paul
    Price, Timothy Jay
    Kim, Tae Won
    Fakih, Marwan
    Ang, Agnes
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [5] Clinical utility of circulating tumor DNA (ctDNA) during disease course of metastatic colorectal cancer (mCRC)
    Lim, Yoojoo
    Kim, Sheehyun
    Kang, Jun-Kyu
    Kim, Hwang-Phil
    Roh, Hanseong
    Kim, Su Yeon
    Lee, Dongin
    Bang, Duhee
    Jeong, Seung-Yong
    Park, Kyu Joo
    Han, Sae-Won
    Kim, Tae-You
    ANNALS OF ONCOLOGY, 2022, 33 : S507 - S507
  • [6] Prediction model for detecting circulating tumor DNA (ctDNA) in metastatic colorectal cancer (mCRC).
    Pereira, Allan Andresson Lima
    Parikh, Aparna Raj
    Van Seventer, Emily E.
    Jia, Jingquan
    Loree, Jonathan M.
    Marie, Preeti Kanikarla
    Raghav, Kanwal Pratap Singh
    Morris, Van K.
    Overman, Michael J.
    Raymond, Victoria M.
    Lanman, Richard B.
    Talasaz, AmirAli
    Strickler, John H.
    Corcoran, Ryan Bruce
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] Clinical utility of upfront circulating tumor DNA (ctDNA) genotyping to guide first-line therapy in patients (pts) with metastatic colorectal cancer (mCRC): A GOZILA substudy.
    Aoki, Yu
    Nakamura, Yoshiaki
    Komatsu, Yoshito
    Taniguchi, Hiroya
    Sunakawa, Yu
    Shiozawa, Manabu
    Kitagawa, Chiyoe
    Ohta, Takashi
    Matsuhashi, Nobuhisa
    Yamazaki, Kentaro
    Boku, Shogen
    Takahashi, Naoki
    Esaki, Taito
    Kawakami, Hisato
    Kagawa, Yoshinori
    Nishina, Tomohiro
    Yamaguchi, Kensei
    Bando, Hideaki
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 157 - 157
  • [8] CIRCULATING TUMOUR DNA (ctDNA) IN PATIENTS WITH METASTATIC COLORECTAL CANCER (mCRC): PROGNOSTIC SIGNIFICANCE AND EARLY CHANGES DURING CHEMOTHERAPY
    Tie, J.
    Kinde, I.
    Wong, H. -L.
    McKendrick, J.
    Singh, M.
    Karapetis, C.
    Desai, J.
    Tran, B.
    Roebert, J.
    Kinzler, K.
    Vogelstein, B.
    Gibbs, P.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 50 - 50
  • [9] Longitudinal monitoring of circulating tumor DNA (ctDNA) during disease course of metastatic colorectal cancer (mCRC)
    Lim, Yoojoo
    Kim, Sheehyun
    Kang, Jun-Kyu
    Kim, Hwang-Phill
    Roh, Hanseong
    Kim, Su Yeon
    Lee, Dongin
    Bang, Duhee
    Jeong, Seung-Yong
    Park, Kyu Joo
    Han, Sae-Won
    Kim, Tae-You
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [10] Circulating tumor DNA (ctDNA) as an early marker to monitor clinical benefit of regorafenib and TAS-102 in patients with metastatic colorectal cancer (mCRC).
    Pereira, Allan Andresson Lima
    Lam, Michael
    Marie, Preeti Kanikarla
    Raghav, Kanwal Pratap Singh
    Morris, Van Karlyle
    Brown, Hiromi
    Windham, Justin
    Duose, Dzifa Yawa
    Overman, Michael J.
    Sanchez, Eduardo Vilar
    Wistuba, Ignacio Ivan
    Kipp, Peter
    Janku, Filip
    Sinha, Sudhir
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345